Laparoscopic liver surgery has dramatically changed the surgical practice in the last decade resulting in improved outcomes in selected patients. Decreased postoperative pain and complications, a shorter hospital stay with an earlier return to work, and aesthetic advantages have been shown from multicentric studies and a recent meta-analysis. (1) (2) (3) With the experience gained during this time, even difficult and complex resections have been done with excellent results. (4) To date, the number of procedures has exceeded 10,000 worldwide after the comparative analysis of the procedures that was conducted during the second International Consensus Conference on Laparoscopic Liver Surgery (2nd ICCLLS) and after the recent European guidelines that showed noninferiority with respect to standard approaches with even better results in selected indications. (5) (6) (7) The success of the procedure has inevitably involved the most delicate and controversial field of living donor hepatectomy.
According to the 2nd ICCLLS, laparoscopic donor hepatectomy for transplantation is classified as Innovation, Development, Exploration, Assessment, Learning (IDEAL) stages. Indeed, experts agree that this procedure should be entrusted to the hands of surgeons with experience in living donation surgery as well as laparoscopic surgery. Because there is no level 1 evidence, the request for determination of benefit/risk ratio (the so-called "balance of harms") is strongly recommended by the introduction of registries. (6) Cherqui et al. first described the laparoscopic left lateral sectionectomy (L-LLS) for adult-to-pediatric donation, which may now be regarded as a standard practice in highly specialized centers. (8, 9) Evidence regarding the use of L-LLS relies upon 2 comparative reports with 16 and 11 patients, respectively. (9, 10) More recently, a comparative "benchmark" study between laparoscopic living donor nephrectomy and L-LLS for pediatric living donor liver transplantation (LDLT) showed that laparoscopic liver donors experienced significantly less overall and less grade 1 or 2 complications than laparoscopic kidney donors. The rates of major complications (grade ≥3) were similar between the 2 groups. (11) With the aim to assess safety, reproducibility, and outcomes following LDLT in children, a comparative single-center series using propensity score matching (PSM) to evaluate open left lateral sectionectomy (O-LLS) versus L-LLS was carried out in 220 consecutive donor hepatectomies in a relatively short time period in a high-volume pediatric transplant center. Results are herein reported.
Patients and Methods

pATIEnTS AnD DATA
A retrospective, observational, single-center, PSM study was conducted after acquiring the necessary approval of the Research Advisory Council (number 2171134) at the King Faisal Specialist Hospital and Research Center (KFSHRC). Demographic, intraoperative, and outcome data from the Electronic Health Record and the Organ Transplant Registry on living donors and liver transplant recipients were extracted and analyzed to evaluate and compare outcomes. Although living donors represent overall a well-selected patient population, we decided to perform a PSM analysis for known confounders during the time period from January 2011 to April 2017 in order to reduce the bias to a minimum. The laparoscopic approach has been used since May 2013 under initial proctorship lasting a total of 3 months with the aim to alleviate the effects of the learning curve and, at the same time, without jeopardizing donor safety. Donors were as follows: fathers in 34.7%, mothers in 31.9%, aunts/uncles in 25%, and others in 8.4% of patients. A written donor informed consent including access to an independent donor advocate (implemented since 2017) was obtained for all patients according to the institutional policy of the KFSHRC. The recipients' immunosuppression protocol consisted of 2 doses of basiliximab (day 1 and 4) combined with tacrolimus, mycophenolate mofetil, and steroids. This protocol was similar in children receiving an ABO-incompatible graft.
SURgICAl TECHnIQUE FoR o-llS
Graft assessment was routinely done by angio-computed tomography volumetry. Donor grafts with double arterial supply and double (separate) venous outflow were not excluded. No radiological assessment of the biliary ducts was performed, and a liver biopsy was rarely done. The donors underwent a J-shaped incision until February 2012; thereafter, a 10-cm midline incision became the standard for open procedures. After checking the arterial supply to segment II, III, and IV, the parenchyma division was systematically performed by using the surgical aspirator (CUSA Excel Valleylab, Integra, Dublin, Ireland) starting on the falciform ligament (transumbilical approach [T-U], Hamburg technique). (12, 13) Clips or ligatures were put on the portal branches to segment IV. Cholecystectomy and intraoperative cholangiography were not done. After reaching the umbilical plate (T-U), attention was paid to preserve whenever possible the arterial supply and the biliary duct of segment IV as well as the portal branches for the caudate lobe. No systemic heparin was administered. Following clamping and transection of Original article | 1021 the left artery, the left portal vein, and the left hepatic vein, the graft was processed for back-table perfusion using 2 L of histidine tryptophan ketoglutarate (HTK) solution (Custodiol, Franz Koehler Chemie, Bensheim, Germany). The time from clamping the inflow until the back-table flushing was measured and defined as first warm ischemia time. Then, 100 mL of HTK solution was injected through the hepatic artery. A hemostatic patch (Tachosil, TakedaNycomed, Osaka, Japan) was put on the resection plan, and a silicone drain was left under suction. The postoperative pain was calculated during the inpatient rounds by using the visual analogue scale (VAS) score. Length of the analgesia requirement was defined as the time between postoperative reawakening and cessation of intravenous administration of nonsteroidal anti-inflammatory drugs or opioids. Standard painkillers consisted of paracetamol 1 g/6 hours and tramadol 50 mg/6 hours given initially intravenously. The patient-controlled analgesia (PCA) consisted of morphine administered through a pump giving a bolus of 1 mg per shot (maximum 15 mg/day). PCA through pump infusion was usually given during the first 3 postoperative days (PODs).
SURgICAl TECHnIQUE FoR l-llS
The technique has been described elsewhere. (14, 15) The donor was tilted to 20°-30° position. Four to 5 trocars (5/10/12/12/5 mm; Applied Medical, Rancho Santa Margarita, CA) were inserted in the upper abdominal quadrants (Fig. 1A,B) . A 30° optical device (Karl Storz, Tuttlingen, Germany) was used. The CO 2 pressure was kept at approximately 10-12 mm Hg. Intraoperative ultrasonography evaluation (Aloka alpha 7, Tokyo, Japan) was done in the first 5 patients to identify anatomical landmarks: the Rex recessus; and the confluence of the left and the middle hepatic vein (MHV), in order to eventually confirm formal anatomical drainage of segments II and III into the left hepatic vein. The falciform and the left triangular ligaments were divided with Ligasure (Medtronic, Minneapolis, MN). After blunt dissection of the liver hilum was done to identify the arterial supply to the left liver and to encircle the left portal vein down to the caudate branches, the parenchyma was divided using the ultrasonic aspirator similar to open surgery.
Similar to the open procedures, the T-U was adopted in almost all of the patients, and no cholecystectomy for intraoperative cholangiography was performed ( Fig. 1C-E) . After dissection of the portal branches to the caudate lobe, a "tunnel" was created between the left side of the caudate lobe and the cutting line to complete parenchymal division until the confluence of the left to the MHV (Fig. 1F,G) . During parenchyma transection, vessels were sealed or clipped using titanium or Hem-o-lock clips (Teleflex, Chicago, IL), whereas the stump of the donor biliary duct was secured by 2 titanium clips or sometimes with stitches ( Fig. 1H,I ). At the end of parenchyma transection ( Fig. 2A,B) , a Pfannenstiel incision was done to allow a Gelport system (Applied Medical) for atraumatic Like in O-LLS, a hemostatic patch was put on the resection plan with a silicone drain under suction ( 
STATISTICAl AnAlYSIS
Categorical variables are expressed as n (%). Continuous data with a normal distribution are reported as mean ± standard deviation (SD) values and compared using 2-sided Student t tests. Continuous data that were not normally distributed are reported as median (range) values and compared with the Mann-Whitney U test. For categorical variables, comparisons between groups were performed using the χ 2 test with the continuity correction, or Fisher's exact test when appropriate. To overcome bias from the different distribution of covariables among patients in the 2 study groups, a PSM analysis was performed in a 1-to-1 match using the nearest-neighbor matching method with no replacement for the following: year of operation, recipient age, indication for transplant, recipient weight, donor sex, donor age, and donor body mass index (BMI). The matching algorithm was based on logistic regression and tested by a histogram of the propensity score, and a dot plot of standardized mean differences. Matching was done when the difference in the logit of the propensity score between the nearest neighbors was within a caliper-width equal to 0.2 times the SD of the logit of the propensity score. Statistical significance was set at P < 0.05. Statistical analysis was performed using SPSS, version 19.0 for Windows (IBM, Armonk, New York).
results
Out of a total of 220 living liver donors for pediatric LDLT, 79 laparoscopic patients were evaluated. Before PSM, only the BMI was significantly higher between open (n = 141; 64%) and laparoscopic (n = 79; 36%) donor procedures: 26. 
opERATIvE DETAIlS
In the L-LLS group, there was a total of 3 (4.2%) conversions to midline laparotomy: in 2 patients, due to a bleeding from the MHV toward its caval confluence; in 1 patient, due to a difficult hilum dissection and unclear anatomy. All the grafts in both groups were successfully implanted. No donors were transfused, and no deaths occurred. The blood loss, overall and minor (Clavien-Dindo grade 1 and 2) morbidity, and hospital stay were significantly lower in the L-LLS group (Table 2) . (16) Similarly, the POD 1 and 4 pain scores (assessed by the VAS) as well as the need of PCA (morphine-based) were significantly less in the L-LLS group (Table 2) . Conversely, the operative time and the first warm ischemia time were longer in the laparoscopic group (Table 2) .
DonoR oUTCoMES
No donor death was recorded. Three (4.2%) donors in the O-LLS group were readmitted within 90 days (early readmission): the first because of a severe urinary tract infection; the second because of pain and vomiting, but no specific complications were diagnosed; and the third because of a wound infection. Late admissions were also recorded in 5 other donors in the same group: in 2 because of an incisional hernia repair (at 27 and 39 months), the third and the fourth due to multiple urinary tract infections and for fragmentation of ureteral stones (both at 30 months). The latter was readmitted due to a hemithyroidectomy for a suspected tumor at 9 months. In the L-LLS group, neither early nor late admissions were recorded at the follow-up. Overall and specific complications are listed in Original article | 1025 NOTE: Data are given as n (%), mean ± SD, or median (range). 
TABlE 3. Details of Donor Complications Between o-llS and l-llS groups
Modified Clavien Grade and Type of Complication O-LLS (n = 72) L-LLS (n = 72)
lIvER gRAFTS AnD RECIpIEnT oUTCoMES
The T-U was possible in 71 (98.6%) donors in the O-LLS group and in 69 (95.8%) donors in the L-LLS group. When not possible, the transhilar procedure was done. The segment IV artery was preserved in more patients in the O-LLS than in the L-LLS group (51%-72.9% versus 40%-55.6% respectively; P = 0.048). Double arterial anastomoses were 5 (7%) and 7 (9.7%) in O-LLS and L-LLS recipients, respectively, whereas a double anastomosis for the biliary ducts was performed in 25 (34.7%) patients in O-LLS and 22 (30.6%) patients in L-LLS. Two portal vein thromboses (both children with portal hypoplasia and portoplasty, serial cases 7 and 16) and 1 hepatic artery thrombosis (positional kinking, serial case 55) occurred in the L-LLS group in the immediate postoperative period and were managed by a revision laparotomy without graft loss. One retransplantation for chronic rejection and 1 for graft dysfunction were performed in the O-LLS and in the L-LLS groups, respectively ( Table 4 ). The incidence of acute cellular rejection was similar in both groups, although the L-LLS group experienced a statistically longer ischemia time, which increases the risk of exposure of hepatocytes to lymphocytes. Moreover, 5 (7%) of the LDLTs in this group were ABO-incompatible transplants and neither immunological events nor increased complication rates or graft loss were recorded at all. Two children (patient 13, female, progressive familial intrahepatic cholestasis [PFIC], 7 months of age, 5.9 kg; and patient 55, female, biliary atresia, 18 months of age, 5.17 kg) who received a graft with the laparoscopic procurement died intraoperatively due to a cardiac arrest after prolonged hypotension and coagulopathy. Both were extremely cachectic (the former also with ascites) and exhibited poor liver function. The total hepatectomy phase was difficult because of massive bleeding, subsequent coagulopathy, and hypovolemic shock. Despite technically successful engraftment, both died at the end of the transplant procedure. A total of 5 children died at the late follow-up in the O-LLS group. Two who were known to have PFIC type 1 with severe allograft steatohepatitis after liver transplantation (a known complication in such condition) died at home from unknown causes after having a viral infection for 2 days without seeking medical advice. Three other children died because of chronic rejection, sepsis, and graft dysfunction (1 each). Similarly, in the L-LLS group, 3 children died for unknown reasons: the first death was due to untreated sepsis at a peripheral hospital; the second child, with severe autoimmune hemolytic anemia (a rare complication after solid organ transplantation), presented with hypovolemic shock and died outside the hospital; the third patient was brought to the emergency room and died on arrival from unknown causes even though all of her laboratory tests prior to that event were within normal ranges. Chronic rejection and post-liver transplantation cardiac surgery led to death in 2 other patients. Overall recipient mortality was 6.9% (n = 5) and 9.7% (n = 7), respectively, for O-LLS and L-LLS groups. The 1-, 3-, and 5-year overall patient survival rates were 98.5%, 90.9%, and BRoERIng ET Al.
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90.9% in the O-LLS group and in the L-LLS group 94.3%, 92.7%, and 86.8% (P = 0.280). The 1-, 3-, and 5-year overall graft survival rates were 98.5%, 90.9%, and 86.6% in the O-LLS group and 94.3%, 88.6%, and 85.2% in the L-LLS group (P = 0.188; Fig. 4 ).
Discussion
Minimally invasive living donor hepatectomies include totally laparoscopic (pure) techniques with suprapubic graft extraction and laparoscopic-assisted (ie, hybrid) techniques consisting of laparoscopic liver mobilization followed by a small incision hepatectomies. According to the 2nd ICCLLS, roughly 442 minimally invasive living donor hepatectomies were reported: the overwhelming majority were hybrid procedures, of which 78% were right lobes, 16% were left lobes, and 6% were LLS. The pure laparoscopic techniques were reported in 85% LLS, 9.5% left lobes, and 5.5% right lobes (R.I. Troisi, personal communication, 2nd ICCLLS, Morioka 2014). From this, we note that the pure laparoscopic techniques have been essentially reserved for LLS grafts and for pediatric LDLT. (9) (10) (11) (18) (19) (20) (21) (22) (23) (24) (25) To the best of our knowledge, this is the largest single-center report comparing the PSM conventional procedure with L-LLS for pediatric liver transplantation. Our data show the safety, reproducibility, and eventually the advantages of the laparoscopic approach in reducing overall donor morbidity. The first comparative analysis by Cherqui et al. reported a longer operative time in the laparoscopic group with significantly decreased blood loss in comparison to the open group. (8) Their experience showed also a trend for a lower overall morbidity with the laparoscopic approach (18.7% and 35.7%, respectively, for laparoscopic and open approach). According to this pioneering experience, the bile leak and the conversion rates were 18.7% and 6.2%, respectively. No differences in hospital stay and self-infused morphine pump administration were recorded. In the second comparative report by Kim et al., the laparoscopic group had a significantly shorter hospital stay and time to oral diet intake, whereas the duration of operation, blood loss, warm ischemia time, and out-of-pocket medical costs were comparable between the open and laparoscopic groups. (10) Significantly higher postoperative transaminases, AST peaks, and ALT peaks were recorded in the laparoscopic group, but no complications occurred. In the largest ever report which should be considered as the benchmark, the conversion rate is 7.9% (63 L-LLS procedures) with a total of 2/63 (3.2%) bile leaks and 17.4% overall complication rates. (11) Accordingly, donor reoperation rate was 3%, and 5 (4%) children needed early liver retransplantation due to vascular events. In our comparative PSM study, the conversion rate is 4.2% with only 1 bile leak and an overall morbidity rate of 4.2% in the laparoscopic approach; no donors required reoperations and no children were retransplanted for vascular events. For the first time, we show that in expert hands the laparoscopic approach can significantly lower overall and liver-specific complication rates displaying similar results in the recipients. Donors in the L-LLS group experienced less pain and went home earlier. In this group, the segment IV artery was preserved in a significantly lower number of patients with respect to the open technique; indeed, fever due to necrosis of this segment was recorded in 1 donor who also experienced the longest postoperative hospital stay. This could partially explain the higher median postoperative peak of AST and ALT levels in the L-LLS group. Finally, the T-U approach was equivalent to using both techniques with a low rate of biliary complications despite the greater number of bile ducts, which is a frequent situation when you go much further to the left side. (26) The reduced blood loss in the laparoscopic group could possibly be explained by the effects of pneumoperitoneum on the hepatic microcirculation and by surgical manipulation. This has already been shown in the clinical and experimental setting. (9, 27) The laparoscopic approach neither compromised donor safety nor put the graft implant procedures at risk in the recipients. The first conversion recorded was necessary to control a bleeding episode due to a displaced clip along the MHV (patient 8). The 2 other conversions were needed because of unclear anatomical and exposure issues (patients 18 and 40) and judged as less safe if continuing the laparoscopic approach. Avoiding the donor risks while preserving at the same time the integrity of the graft were the principles which guided us in deciding to convert. Indeed, the hand-assisted technique could decrease the warm ischemia time and facilitate technical difficulties during the division of the liver parenchyma. (28) However, our major goal was the preservation of the donor's abdominal wall integrity since we do think, like others, that the hand-assisted technique with a midline or subcostal incision might lower the advantages of the technique. According to this concept, we decided to establish a pure laparoscopic living donor hepatectomy program under a proctorship. (9, 10) In our opinion, the cutting point of the bile ducts, the atraumatic dissection of the hilum, and the maintenance of a proper dissection plan without damaging the hepatic veins represent the challenges of the procedure. The transumbilical approach and the "hanging over" maneuver through the hole behind the hilar plate with the Goldfinger dissector may facilitate the progression of the laparoscopic parenchymal transection. (29) Indocyanine green (ICG) technology has been applied first by our group during laparoscopic donor hepatectomy and is able to help surgeons understand the biliary anatomy as one of the most important anatomical landmarks. (15, 30, 31) The perioperative mortality and vascular complication rates in the recipients were similar to the results displayed in a recent multicentric benchmark experience. (11) The vascular events recorded in 3 recipients in the L-LLS group were diagnosed in the immediate postoperative period and successfully surgically managed with excellent graft outcomes. Therefore, we cannot directly link these complications to a hypothetical but still possible more extensive or overlooked laparoscopic manipulation. Some children received a larger-for-size graft (ie, >4% body weight ratio) and were managed with a temporary abdominal closure. The definitive closure was achieved within a few days providing the stabilization of the graft flows at the Doppler examination. This approach neither modified our standard protocol (ie, early extubation) because of a planned reoperation nor increased the overall complication rates. (32) Unfortunately, 50% of the late mortalities we experienced were due to unknown reasons and chronic rejection. This is most likely attributed to the far distance of the peripheral hospitals, which have little or no experience in treating pediatric liver transplant recipients. Indeed, the KFSHRC is the only high-volume pediatric liver transplant center in Saudi Arabia. The accumulation of experience in living liver donation will possibly reduce overall complications. Donor morbidity in our experience is very low. This reflects the combined role of the acquired experience in the field of donor hepatectomy together with the advantageous effects of the standardization of the laparoscopic techniques for left lateral sectionectomy. (19) Data from 4 European specialized hepatobiliary units have shown that the "self-taught" learning curve of the L-LLS could be considered completed after the surgeon had performed 15 procedures. (33) Yet, no data are available on the learning curve of the L-LLS for living liver donation. This report also highlights the importance and the advantages of using proctoring from an expert when shifting to a different approach in donor hepatectomies where donor safety is of paramount importance. The result of this project is that the L-LLS for living donation has become a standard practice in our institution, with the only limitation Original article | 1029 being represented by some local logistic factors. Striving to a higher level of evidence for laparoscopic liver surgery in general and, specifically, in laparoscopic donor hepatectomy is extremely difficult. Most likely, the perceived risks for the donors, the complexity of the procedures, the variability of the learning curve, the relatively small number of indications for pediatric transplantation, and the competing splitliver policies are the main causes hindering the development of the laparoscopic approach. Consequently, more robust data on short-term and longterm outcomes are required before promoting the implementation of the laparoscopy as highlighted by the 2nd ICCLLS and by the European Guidelines Meeting on Laparoscopic Liver Surgery. (6, 7) National and international registries could possibly provide meaningful data by allowing for a risk-benefit analysis. (7) Interesting results coming from the application of the benchmark concept to measure performance by comparing the laparoscopic kidney donor nephrectomy (a well-standardized and worldwide accepted procedure) with an innovative one represented by the L-LLS for pediatric LDLT have been recently reported. (11) Both procedures showed similar short-term outcomes with a significantly lower morbidity than those recorded after laparoscopic kidney donation according to the comprehensive complication index. This would allow us to consider the L-LLS in the hands of experienced teams as a new standard practice for segment II and III graft procurement in pediatric liver transplantation. (9, 11) We strongly advocate that such a procedure should be carried out only by surgical teams with vast expertise in liver transplantation, with living donor liver grafts, and minimally invasive liver surgery. (6, 7, 9, 10, 19) In conclusion, this study provides an additional validation for the full L-LLS for living donor hepatectomy. This is a safe but also a reproducible procedure in the hands of experienced surgeons dealing with complex liver surgery and liver transplantation, including split-liver transplantations and LDLTs. We demonstrated that the proctorship of experienced "open" liver surgeons dealing with complex liver procedures may further lower donor morbidity, alleviating the ethical pressure on this matter and the actual criticisms due to the innovative characteristic of the procedure itself. Following the statements on laparoscopic living donor hepatectomy formulated during the 2nd ICCLLS, we demonstrated herein that this innovative technique yields significant short-term outcome advantages for the donors, can be taught and reproduced with excellent results, and, therefore, should be encouraged worldwide provided that the best conditions and the right commitments are fulfilled.
